AXOVANT GENE THERAPIES LTD

CUSIP: G0750W203 Class: COM

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 4,156 Value ($000) $19 Avg Close — Range —
Q2 2020
Shares 1,334 Value ($000) $4 Avg Close — Range —
Q4 2019
Shares 4,469 Value ($000) $23 Avg Close — Range —
Q3 2019
Shares 36,517 Value ($000) $236 Avg Close — Range —
Q2 2019
Shares 29,144 Value ($000) $182 Avg Close — Range —